Hybrid eventIn-person & virtual
June 24–26, 2027Rome, Italy
Session Track · Neurology 2027 · Track 33

Neuropharmacology and Novel Drug Development at Neurology 2027

Part of the Neurology 2027 scientific program · Rome, Italy · June 24–26, 2027

About the Neuropharmacology and Novel Drug Development Session

Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.

Featured Speakers — Neuropharmacology and Novel Drug Development 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Neuropharmacology and Novel Drug Development Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at Neurology 2027

Why Attend the Neuropharmacology and Novel Drug Development Conference 2027

Present Your Research

Oral and poster slots for original Neuropharmacology and Novel Drug Development work, reviewed by the scientific committee.

Network Globally

Meet researchers, academics, and practitioners from around the world throughout the conference.

Learn from Keynotes

Plenary lectures from leading voices shaping Neuropharmacology and Novel Drug Development research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join Neurology 2027 for the Neuropharmacology and Novel Drug Development track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Neuropharmacology and Novel Drug Development Conference 2027 — FAQs

What is the Neuropharmacology and Novel Drug Development track at Neurology 2027?

The Neuropharmacology and Novel Drug Development track is a dedicated stream within Neurology 2027 covering the latest research, innovation, and best practice in Neuropharmacology and Novel Drug Development. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Neuropharmacology and Novel Drug Development sessions?

Researchers, academics, practitioners, doctoral students, and industry professionals with an interest in Neuropharmacology and Novel Drug Development are all welcome — whether presenting or attending.

Can I present my research in the Neuropharmacology and Novel Drug Development track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.

Is virtual attendance available for Neuropharmacology and Novel Drug Development sessions?

Yes. Neurology 2027 is a hybrid conference — attend the Neuropharmacology and Novel Drug Development track in person in Rome or join live online.

Join the Neurology 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.